期刊文献+

BRAF基因与甲状腺癌分子诊疗的研究进展 被引量:13

下载PDF
导出
摘要 对甲状腺结节进行细针穿刺细胞学检查,给临床医生诊断甲状腺肿瘤提供了一个新的信息。该技术在甲状腺癌的临床诊断中,特别是BRAF基因的应用,在一定程度上提高了甲状腺癌诊疗水平。国内外最新研究表明,BRAF基因检测为甲状腺癌的诊断和预后提供了参考,并给临床上甲状腺癌的初始化治疗指明了一个方向。对于临床细针穿刺细胞学检测不能确定的甲状腺癌,BRAF分子检测技术可作为一个有用的检测手段,为临床诊断甲状腺癌提供一个决定性的参考,使更多的甲状腺癌患者得到个体化的治疗。本文就BRAF基因与甲状腺癌分子诊疗的关系进行综述。
出处 《中国医学创新》 CAS 2013年第2期161-163,共3页 Medical Innovation of China
  • 相关文献

参考文献17

  • 1Nikiforov Y E. Molecular diagnostics of thyroid tumors[J].{H}ARCHIVES OF PATHOLOGY AND LABORATORY MEDICINE,2011,(24):569-577.
  • 2应敏刚,陈建顺,肖景榕,陈增春,周衍.长乐市1988~2002年恶性肿瘤发病率时间趋势分析[J].中国肿瘤,2005,14(1):32-34. 被引量:21
  • 3吕云福,顾文彪,谢贤和.甲状腺癌相关肿瘤分子标志物研究进展[J].国际外科学杂志,2011,38(2):92-96. 被引量:14
  • 4Theoharis C G,Schofield K M,Hammers L. The Bethesda thyroid fineneedle aspiration classification system:year 1 at an academic institution[J].{H}THYROID,2009,(06):1215-1223.
  • 5Jo V Y,Stelow E B,Dustin S M. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology[J].{H}American Journal of Clinical Pathology,2010,(24):450-456.
  • 6Baloch Z W,Livolsi V A,Asa S L. Diagnostic terminology and morphologic crieria for cytologic diagnosis of thyroid lesions:a synopsis of the National Cancer Institute Thyroid FNA State of the Science Conference[J].{H}Diagnostic Cytopathol,2008,(14):425-437.
  • 7沈樑,黄颖烽,梁柳森,陈润成,罗宏图,张帅,叶志东.甲状腺癌前哨淋巴结微转移分子检测及其临床意义[J].临床医学,2008,28(11):98-99. 被引量:5
  • 8Ikawa S,Fukui M,Ueyama Y. B-raf,a new member of the raf family,is activated by DNA rearrangement[J].{H}Molecular and Cellular Biology,1988,(06):2651-2654.
  • 9Ji H,Wang Z,Perera S A. Mutations in BRF and KRS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models[J].{H}CANCER RESEARCH,2007,(10):4933-4939.
  • 10Xing M,Tufano R P,Tufaro A P. Detection of BRAF mutation on fine needle aspiration biopsy specimens:a new diagnostic tool for papillary thyroid cancer[J].{H}Journal of Clinical Endocrinology and Metabolism,2004,(42):2867-2872.

二级参考文献50

  • 1项永兵,金凡,袁剑敏,孙璐,高玉堂.肿瘤登记资料统计分析的微机实用软件[J].中国慢性病预防与控制,1994,2(2):74-76. 被引量:5
  • 2杨清绪,邵春奎,冯智英,黄本强,韩安家,熊敏,赵文丽,武彤彤.CK19和甲状腺过氧化物酶表达在甲状腺疾病诊断中的作用[J].第一军医大学学报,2005,25(6):678-681. 被引量:12
  • 3Arch -Ferrer J, Velazquez D, Fajardy K, et al. Accuracy of sentinel lymph node in papillary thyroid carcinoma [ J ]. Surgery, 2001,130 : 907 -913.
  • 4Noguchi S, Hiratsuka M, Furukawa H, et al. Detection of gastric cancer micrometastasis in axilly lymph node by amplification of K19 mRNA with RT - PCR[ J]. Cancer Res, 1996,87 ( 6 ) :650 - 654.
  • 5Caron NR, Clark OH. Papillary thyroid cancer: surgical management of lymph node metastases[ J]. Curr Treat Options Oncol,2005,6(4) : 311 -322.
  • 6Keleman PR, Van Herle A J, Gliuiano AE. Sentinel lymphadenectomy in thyroid malignant neoplasms[ J]. Arch Surg, 1998, 133 (3) :288 -292.
  • 7Tsugawa K, Ohnishi I, Nakamura M, et al. Lntraoperative lymphatic mapping and sentinel lymph node biopsy in patients with papillary carcinoma of thyroid glamel [ J ]. Biomed Pharmacother, 2002, 56:100 - 103.
  • 8De Matos PS,Ferreira AP,De Oliveira,et al. Usefulness of HBME, cytokeratin 19 and galectin -3 immunostaining in the diagnosis of thyroid malignancy [ J ]. Histopathology, 2005,47 ( 4 ) : 391 - 401.
  • 9Hamatani K,Eguchi H,Ito R,et al.RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose[J].Cancer Res,2008,68(17):7176-7182.
  • 10Nakashima M,Takamura N,Namba H,et al.RET oncogene amplification in thyroid cancer:correlations with radiation-associated and high-grade malignancy[J].Hum pathol,2007,38(4):621-628.

共引文献37

同被引文献146

引证文献13

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部